back to top
HomeSTOCKSBuy These 5 Stocks For Bumper Returns, Buying Advice For Returns Up...

Buy These 5 Stocks For Bumper Returns, Buying Advice For Returns Up To 30%

Hot Stocks Alert Join

Top-5 Stocks to Buy: The effect of tension in the Middle East is also being seen on the domestic stock markets. Heavy selling was seen in the last two trading sessions. 

Amidst the ongoing fluctuations in the market, brokerage firm has made selected stocks of the pharma sector its top pick. These stocks can be kept in the portfolio with a long-term perspective. 

These stocks include Cipla, Aurobindo, Ajanta Pharma, Piramal Pharma, and Abbott India. The brokerage says that investors can get excellent returns of up to 28 percent in these stocks in the next one year.

Cipla Ltd

Brokerage firm has given buying advice on Cipla stock. The target per share is Rs 1,660. On April 16, 2024, the share price closed at Rs 1379. In this way, a 21 percent return can be given on the stock in the future.

Aurobindo Pharma Ltd

Brokerage firm has given buying advice on Aurobindo’s stock. The target per share is Rs 1,270. On April 16, 2024, the share price closed at Rs 1110. In this way, a 15 percent return can be given on the stock.

Ajanta Pharma Ltd

Brokerage firm has given buying advice on the stock of Ajanta Pharma. The target per share is Rs 2,385.

On April 16, 2024, the share price closed at Rs 2066. In this way, a 15 percent return can be given on the stock.

Piramal Pharma Ltd

Brokerage house has given buying advice on the stock of Piramal Pharma. The target per share is Rs 180.

On April 16, 2024, the share price closed at Rs 141. In this way, a 28 percent return can be given on the stock in the future.

Abbott India Ltd

Brokerage firm has given buying advice on Abbott India stock. The target per share is Rs 33000. On April 16, 2024, the share price closed at Rs 26,209.

In this way, a 26 percent return can be given on the stock in the future.

Disclaimer: The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations. We are here to provide timely updates about the stock market and financial products to help you make better investment choices.

BEST FOR YOU

LEAVE A REPLY

Please enter your comment!
Please enter your name here